Related by context. Frequent words. (Click for all words.) 71 Initiates Phase II 70 Completes Patient Enrollment 69 Announces FDA Clearance 69 fibrosis IPF 69 addressing idiopathic pulmonary 68 oncolytic virus therapies 67 Receives Orphan Drug Designation 67 R sorafenib tablets 67 ® bortezomib 66 deCODE AF TM 66 Nasdaq MITI biopharmaceutical 66 LungAlert TM 66 BioGlue R 66 non nucleoside inhibitor 66 Announce Merger Agreement 66 Enrolls First 66 Genentech Wyeth Pharmaceuticals 66 Therapeutic Competitors companiesandmarkets.com adEgemonye 66 Inc. Nasdaq ELGX 65 Bilive R combined 65 Inc Therapeutic Competitors 65 Presents Positive 65 FDA Clears 65 Hepatitis C HCV 65 Completes Enrollment 65 Therapeutic Competitors Report 65 www.vivus.com 64 Through Glycoscience R 64 thetreatment 64 MKC# MT 64 Taiho Pharmaceutical 64 candidate XP# 64 cystic fibrosis inflammation autoimmune 64 Presents Preclinical Data 64 Maven Semantic 64 R sipuleucel T 64 commercializing therapeutic 64 ALN HTT 64 Biomagnetics Diagnostics Corporation 63 AMEX ISV 63 ophthalmics 63 gets USFDA nod 63 Adenosine Therapeutics 63 http:/www.palatin.com 63 staphylococcal vaccines 63 intranasal formulation 63 Sign License Agreement 63 Announces Licensing Agreement 63 Novel Oral 63 Demonstrates Significant 63 FDA Accepts 63 Nasdaq ENMD 62 XL# XL# 62 refractory chronic lymphocytic 62 Completes Previously Announced 62 MKC# 62 Catalyst Biosciences 62 treat male hypogonadism 62 menopause contraception 62 Therapeutic Competitors 62 Earnings Postmortem 62 Meets Primary Endpoint 62 FOLOTYN ® 62 Submits Application 62 inflammation autoimmune diseases 62 BioMarin develops 62 Inc. Nasdaq IMGN 62 Surgical Adhesive 62 DELATESTRYL R 62 Alferon LDO 62 ATS CryoMaze TM 62 MassARRAY R 62 www.sorin.com 62 GVAX R 62 DNA methyltransferase inhibitors 62 targeted immunotherapies 62 Adamis Pharmaceuticals 62 CombinatoRx Incorporated 62 Vicriviroc 62 oncology infectious diseases 61 Daclizumab 61 inflammatory autoimmune diseases 61 catheter occlusion 61 Patient Enrollment 61 orthobiologic 61 pediatric Crohn disease 61 NASDAQ LGND 61 Florbetapir 61 Inc. Nasdaq OSTE 61 KAI Pharmaceuticals 61 topical non steroidal 61 Nasdaq RGDX 61 Iluvien ® 61 SUPPRELIN R LA 61 Dyax logo 61 Patients Treated With 61 ophthalmology dermatology 61 Receives Favorable 61 ORLive Presents 61 #-# Full Text 61 Trofex